Amedisys Inc/ US0234361089 /
| 11/15/2024 10:00:00 PM | Chg. -0.2400 | Volume | Bid10:23:24 PM | Ask10:23:24 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 90.0500USD | -0.27% | 501,387 Turnover: 34.4 mill. |
89.0000Bid Size: 100 | 91.9700Ask Size: 100 | 2.95 bill.USD | - | - |
Assets
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 36.9990 | 31.1000 | 29.4490 | 28.1000 | 23.7000 | ||||||
| Intangible Assets | 46.7550 | 46.0610 | 44.1320 | 64.7000 | 74.2000 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 519.1190 | 502.3260 | 493 | 912.1910 | 1,205.2140 | ||||||
| Inventories | - | - | - | - | - | ||||||
| Accounts Receivable | 166.0560 | 201.1960 | 188.9720 | 237.5960 | 255.1450 | ||||||
| Cash and Cash Equivalents | 30.1970 | 86.3630 | 20.2290 | 30.3000 | 81.8000 | ||||||
| Current Assets | 214.9100 | 311.1560 | 224.1180 | 350.5540 | 361.9840 | ||||||
| Total Assets | 734.0290 | 813.4820 | 717.1180 | 1,262.7450 | 1,567.1980 | ||||||
Liabilities
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 30.3580 | 25.3840 | 28.5310 | 31.2590 | 42.6740 | ||||||
| Long-term debt | 87.8090 | 78.2000 | 5.7750 | 232.3000 | 204.5000 | ||||||
| Liabilities to Banks | 93 | 88.8000 | 5.8000 | 232.3000 | - | ||||||
| Provisions | - | - | 1.6000 | 37.7000 | - | ||||||
| Liabilities | 272.8870 | 297.0560 | 234.4850 | 621.2320 | 756.4570 | ||||||
| Share Capital | .0350 | .0350 | .0360 | .0370 | .0380 | ||||||
| Total Equity | 461.1420 | 516.4260 | 482.6330 | 641.5130 | 810.7410 | ||||||
| Minority Interests | .9390 | 1.1050 | 1.0510 | 1.0630 | 1.5170 | ||||||
| Total liabilities equity | 734.0290 | 813.4820 | 717.1180 | 1,262.7450 | 1,567.1980 | ||||||
Income Statement
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 1,437.4540 | 1,533.7000 | 1,662.5780 | 1,955.6000 | 2,071.5000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 57.3400 | 78.5240 | 155.1000 | 177.5000 | 219.3000 | ||||||
| Interest Income | -5.0890 | -4.8730 | -7.0920 | -14.4370 | -10.7460 | ||||||
| Income Before Taxes | 61.5660 | 80.8010 | 158.9880 | 170.4100 | 210.8190 | ||||||
| Income Taxes | -23.9350 | -50.1000 | -38.8590 | -42.5000 | -25.6000 | ||||||
| Minority Interests Profit | -.3700 | -.3820 | -.7830 | -1.0740 | -1.5760 | ||||||
| Net Income | 37.2610 | 30.3000 | 119.3460 | 126.8000 | 183.6000 | ||||||
Per Share
Cash Flow
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 62.2590 | 105.7310 | 223.4830 | 202 | 288.9520 | ||||||
| Cash Flow from Investing Activities | -52.0490 | -44.0270 | -22.1930 | -352.9480 | -287.1080 | ||||||
| Cash Flow from Financing | -7.5150 | -5.5380 | -267.4240 | 227.2090 | -14.9770 | ||||||
| Decrease / Increase in Cash | 2.6950 | 56.1660 | -66.1340 | 76.2610 | -13.1330 | ||||||
| Employees | 16,000 | 17,900 | 21,000 | 21,300 | - | ||||||
